Abstract

Emerging evidence suggests that cellular metabolism plays a critical role in regulating immune activation. Alterations in energy and lipid and amino acid metabolism have been shown to contribute to type I interferon (IFN) responses in macrophages, but the relationship between metabolic reprogramming and the establishment of early antiviral function remains poorly defined. Here, we used transcriptional profiling datasets to develop global metabolic signatures associated with early IFN-α responses in two primary macrophage model systems: mouse bone marrow-derived macrophages (BMM) and human monocyte-derived macrophages (MDM). Short-term stimulation with IFN-α (<4 hours) was associated with significant metabolic rewiring, with >500 metabolic genes altered in mouse and human macrophage models. Pathway and network analysis identified alterations in genes associated with cellular bioenergetics, cellular oxidant status, cAMP/AMP and cGMP/GMP ratios, branched chain amino acid catabolism, cell membrane composition, fatty acid synthesis, and β-oxidation as key features of early IFN-α responses. These changes may have important implications for initial establishment of antiviral function in these cells.

Highlights

  • Type I interferons (IFN) (IFN-α and IFN-β) play a seminal role in antiviral, antibacterial, and antitumour responses and act as critical regulators of the innate and adaptive immune system [1,2,3,4,5]

  • Our findings provide a systematic understanding of altered metabolic genes associated with early IFN-α responses in bone marrow-derived macrophages (BMM) and monocyte-derived macrophages (MDM) and identify potential metabolic mechanisms that may contribute to initial establishment of antiviral immune responses

  • Two hundred and eighty-five gene sets were enriched in BMM distributed across three main functional categories including immune signaling and function (n = 151), cellular metabolism (n = 40), and other biological states and processes (n = 94)

Read more

Summary

Introduction

Type I interferons (IFN) (IFN-α and IFN-β) play a seminal role in antiviral, antibacterial, and antitumour responses and act as critical regulators of the innate and adaptive immune system [1,2,3,4,5]. Stimulation with type I IFNs has been shown to increase glycolytic flux, inhibit sterol biosynthesis, shift lipid metabolism from de novo synthesis to lipid import, and increase tryptophan catabolism [20,21,22,23,24,25]. This metabolic reprogramming is required to mount functional antiviral responses and has been shown to regulate antigen presentation, inflammatory mediator production, phagocytosis efficiency, and intracellular killing [26, 27]. Recent studies suggest metabolic adaptations in macrophages occur at the molecular level (i.e., gene expression) very early during the process activation and functional

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call